Produktinformation
- 6-Methoxybaicalein, Baicalein 6-methyl ether
- 4H-1-Benzopyran-4-one, 5,7-dihydroxy-6-methoxy-2-phenyl-
- 5,7-Dihydroxy-6-methoxy-2-phenyl-4H-1-benzopyran-4-one
- 5,7-dihydroxy-6-methoxy-2-phenyl-4H-chromen-4-one
- 6-Methoxybaicalein
- Baicalein 6-methyl ether
- Flavone, 5,7-dihydroxy-6-methoxy-
- Oroxylin
- oroxylin A
1. Oroxylin A (Baicalein 6-methyl ether) has various anti-tumor effects including apoptosis, cell cycle arrest, drug-resistant reversion. 2. Oroxylin A possesses abilities of inhibiting the ATRA-induced IL-6 production via modulation of LAP/LIP/CHOP in leukemia cell lines, which could providing a therapeutic strategy for RAS. 3. Oroxylin A inhibits UCP2s triggers the MPTP opening, and promotes the apoptosis in CaCo-2 cells; uncoupling protein 2 plays a key role in mitochondrial apoptotic pathway. 4. Oroxylin A inhibits N1ICD translocating to the nucleus and binding to epithelial-mesenchymal transition-related transcription factor Snail, thus suppressing the invasion and migration of MCF-7 cells. 5. Oroxylin A improves the sensitivity of K562/ADM cells by increasing apoptosis in leukemic cells and decreasing the expression of CXCR4 and PI3K/Akt/NF-κB pathway, and probably served as a most promising agent for CML treatment.
Chemische Eigenschaften
Technische Anfrage zu: TM-T6S1315 Oroxylin A
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.